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Objective: Myocardial ischemia and reperfusion induced by cardioplegic
arrest subjects the heart to free radical-mediated stress. The purpose of
our study was to investigate the effect of cardioplegia-induced ischemia
and reperfusion on myocardial formation and distribution of (1) nitroty-
rosine as an indicator for peroxynitrite-mediated tissue injury resulting
from increased nitric oxide release and (2) 8-isoprostane as an indicator
for oxygen-derived free radical-mediated lipid peroxidation.
Methods: In 10 patients undergoing coronary artery operations (64  6
[mean  SD] years, 3 women and 7 men) subjected to cardiopulmonary
bypass and intermittent cold blood cardioplegia, we collected transmural
left ventricular biopsy specimens before and at the end of cardiopulmo-
nary bypass. Specimens were cut at 10 m and subjected to immunocy-
tochemical staining against the nitric oxide-producing enzyme constitu-
tive nitric oxide synthase, cyclic guanosine monophosphate (intracellular second
messenger of nitric oxide), nitrotyrosine, and 8-isoprostane by using polyclonal
antibodies. For global left ventricular function determination, we measured the
fractional area of contraction using transesophageal echocardiography.
Results: Nitric oxide synthase activity in cardiac myocytes increased from 34 10 gray
units before cardiopulmonary bypass to 47  12 gray units at the end of bypass (P 
.015), and all hearts showed increased cyclic guanosine monophosphate content in both
myocytes and endothelial cells at the end of bypass. The number of nitrotyrosine-
positive capillaries increased from 36  29/mm2 before bypass to 82  47/mm2 at the
end of bypass (P  .012), and 8-isoprostane-positive capillaries increased from 92 
72/mm2 before bypass to 209 108/mm2 at the end of bypass (P .005). The fractional
area of contraction was 53% 12% before bypass and 56% 12% after bypass (P .47)
but was slightly decreased to 45%  14% at 4 hours after bypass (P  .121).
Conclusions: Our data show that cardioplegia-induced myocardial ischemia and
reperfusion is associated with nitrotyrosine and 8-isoprostane formation mainly
in the coronary endothelium, indicating injury mediated by both peroxynitrite
and oxygen-derived free radicals. Because nitric oxide synthase activation was
accompanied with increased cyclic guanosine monophosphate, these data sug-
gest that direct effects of nitric oxide on cardiac myocytes, as well as nitric
oxide–mediated coronary endothelial injury, might contribute to injury associ-
ated with cardioplegia and cardiopulmonary bypass.
Myocardial ischemia and reperfusion subjects the heart to stressmediated by free oxygen radicals or reactive oxygen species(ROS), such as hydroxyl radical (OH), superoxide radical(O2), hydrogen peroxide (H2O2), and peroxynitrite (NO3),the product of nitric oxide (NO) binding to O2.1-3 ROS arethought to mediate the reperfusion injury that characterizes
metabolic, structural, and functional (stunning) myocardial damage associated with
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experimental coronary occlusion and reperfusion.1-3 How-
ever, little evidence of such a relationship exists in human
subjects. This is in part due to the limitations intrinsic to
available indices of ROS-mediated tissue injury in vivo.4
Thus clinical investigators have mainly relied on ex vivo
spin-trapping techniques and determination of indirect evi-
dence for ROS-mediated lipid peroxidation, such as malon-
dialdehyde and lipid hydroxyperoxydase determination, in
the blood of patients with acute myocardial infarction5 or
those subjected to percutaneous transluminal coronary an-
gioplasty6 or coronary artery bypass grafting (CABG).7
More recently, a number of novel assays of more stable
ROS-mediated tissue injury markers, such as 8-iso-prosta-
glandin-F2 (8-iosprostane)1,8 and nitrotyrosine9,10 have
been described. 8-Isoprostane is the stable end product of
arachidonic acid oxidation generated by ROS attacks on
membrane phospholipids.11 Nitrotyrosine represents the sta-
ble end product of cell membrane protein-bound tyrosine
nitration by peroxynitrite caused by increased NO.9
We have recently shown, in patients undergoing CABG,
that cardioplegia-induced myocardial ischemia and reperfu-
sion activates the NO-producing enzyme constitutive NO
synthase (constitutive NOS or NOS-III) in cardiac myocytes
and endothelium, leading to increased NO release.12 In
addition, Hayashi and colleagues13 demonstrated that hu-
man myocardium produces peroxynitrite during reperfusion
after cardioplegic arrest. These data suggest that peroxyni-
trite-mediated nitrotyrosine formation caused by NOS-III
activation and NO release might contribute to ROS-induced
reperfusion injury after cardioplegic arrest. However, direct
evidence for cardioplegia-induced reperfusion injury by
ROS is still lacking. Therefore the purpose of our study was
to investigate the effect of cardioplegia-induced ischemia
and reperfusion on myocardial formation and distribution of
nitrotyrosine as an indicator for peroxynitrite-mediated tis-
sue injury and 8-isoprostane as an indicator for ROS-medi-
ated lipid peroxidation.
Material and Methods
Patients
After obtaining approval from the University of Cologne Human
Ethics Committee, written informed consent was obtained from
each patient during the preoperative interview. Ten patients sched-
uled for elective coronary artery surgery (Table 1) were included
in the study. Patients were subjected to cardiopulmonary bypass
(CPB) at 32°C to 34°C, the aorta was crossclamped, and intermit-
tent (every 20 minutes) cold (6°C-8°C) antegrade blood cardio-
plegia with hot shot before crossclamp removal (according to the
method of Buckberg) was administered.
Clinical Protocol
After anesthesia induction and standard hemodynamic monitoring,
a 5-MHz transesophageal echocardiography probe (Vingmed CFM
800°; Sonotron, Horten, Norway) was placed to provide a left
ventricular (LV) short-axis image at the midpapillary level. From
the transesophageal echocardiography recordings, we derived the
fractional area of contraction (FAC) as a measure of LV ejection
fraction before cannulation for CPB, at 10 to 15 minutes after
weaning from CPB, and at 4 hours after CPB in the intensive care
unit.14
LV Biopsy Specimens
Before CPB initiation, we collected a transmural biopsy specimen
from a fat-free area of the LV anterior wall using a 14-gauge
biopsy needle (Gallini, Modena, Italy). A second LV biopsy spec-
imen was taken at the end of the extracorporeal circulation before
weaning from CPB. All LV biopsy specimens were placed in 4%
paraformaldehyde for 4 hours and then rinsed in 0.1 mol/L phos-
phate-buffered saline (PBS) solution for 24 hours, followed by
storage for 12 hours in PBS solution with 18% sucrose for cryo-
protection, and frozen at 80°C. Because 4% paraformaldehyde
has been shown to result in optimal fixation of cyclic guanosine
monophosphate (cGMP) on the cell’s protein matrix,15 we used
this solution for immunohistochemical detection of the water-
soluble cGMP.
Immunocytochemistry
Before immunohistochemical examination, 10-m slices from the
biopsy specimens were placed in a bathing solution of 3% H2O2
and 60% methanol PBS for 30 minutes and then permeabilized
with 0.2% Triton-X 100 in 0.1 mol/L PBS. Thereafter, specimens
were treated with 5% normal goat serum and 5% bovine serum
albumin solution in PBS. Before each step, the sections were
rinsed 3 times in PBS buffer. Incubation with primary polyclonal
rabbit anti-NOS-III antibody (Biomol, Hamburg, Germany) at a
dilution of 1:1500 was performed in a PBS-based solution of 0.8%
bovine serum albumin and 20 mmol/L NaN3 for 12 hours at 4°C.
For cGMP detection, we used a polyclonal rabbit anti-cGMP
antibody (Quartett, Hamburg, Germany) at a dilution of 1:600.
After rinsing with PBS, the sections were incubated with the
corresponding secondary biotinylated goat anti-rabbit antibody
(Vector Laboratories, Burlingame, Calif) for 1 hour at room tem-
perature. For nitrotyrosine staining, we used a monoclonal mouse
anti-nitrotyrosine antibody (Calbiochem, San Diego, Calif) at
TABLE 1. Patient data
Patients (n) 10
Female/male (n) 3/7
Age (y) 63.7 6.3
Height (cm) 168.7 7.0
Weight (kg) 78.8 9.7
1/2/3-Vessel disease (n) 0/1/9
Angiographic LV ejection fraction (%) 64.4 11.7
LVEDP (mm Hg) 13.3 8.3
Grafts per patient (n) 3.5 0.5
LITA to LAD (n) 1.0 0.0
CPB duration (min) 95.8 14.9
AXC duration (min) 56.5 10.1
Postoperative CK-MBmax (U/L) 12.9 4.8
Perioperative myocardial infarction (n) 0
LVEDP, Left ventricular end-diastolic pressure; LITA,, left internal thoracic
artery; LAD, left anterior descending artery; AXC, aortic crossclamp; CK-
MB, creatine kinase MB fraction. Data are given as mean  SD.
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1:400 and a secondary goat anti-mouse antibody (DAKO, Weis-
loch, Germany) at 1:400; for 8-isoprostane detection, a polyclonal
goat anti-8-Epi-PGF2a antibody (Oxford Biomedical Research,
Oxford, Mich) at 1:1500 and a secondary rabbit anti-goat antibody
(DAKO, Germany) at 1:400 was used. A streptavidin-horseradish
peroxidase complex was then applied as a detection system (1:100
dilution) for 1 hour. Finally, staining was developed for 3 to 5
minutes with 3,3-diaminobenzidine tetrahydrochloride in 0.05
mol/L TRIS-HCl buffer and 0.1% H2O2.
NOS-III Television Densitometry
All LV biopsy slices were incubated and stored under identical
conditions. For intensity analysis of NOS-III immunostaining in
cardiomyocytes, we measured the gray values of 50 cardiomyo-
cytes from 10 randomly selected areas. The intensity of immuno-
staining was reported as the mean of measured cardiomyocyte gray
value minus background gray value. The background gray value
was measured at a cell-free area of the slice. For staining intensity
detection, a Zeiss Axiophot microscope coupled to a 3-chip CCD
camera was used, and the analysis was performed by using the
Optimas 6.01 image analysis program installed on a Pentium
personal computer.
cGMP Semiquantitative Analysis
For semiquantitative analysis of myocardial cGMP content, we
used a score to differentiate between no change and clearly in-
creased cGMP content. All specimens were independently judged
by 2 investigators in a blind fashion. Any disagreement between
judgements was subsequently resolved by discussion.
Nitrotyrosine and 8-Isoprostane Quantification
Quantitative analysis was performed on 5 randomly selected fields
(66,125 m2 per frame) of LV biopsy cross-sections. All immu-
nohistochemically stained capillaries per field were counted with a
Zeiss Axiophot microscope with a 40 oil immersion objective
and expressed as number per square millimeter.
Statistical Analysis
All data are presented as mean  SD. Data were analyzed for
statistical significance on an  levels of 5% by using the 2-tailed
Student t test for paired samples, as implemented in the software
package SASS for Windows, version 10.0. The P values reported
are not adjusted for multiple testing.
Results
Myocardial immunostaining for NOS-III, cGMP, nitroty-
rosine, and 8-isoprostane is depicted in Figure 1. Compared
with before CPB (Figure 1, upper line), NOS-III activity
and cGMP content were increased in both cardiac myocytes
and endothelial cells at the end of CPB (Figure 1, lower
line). Nitrotyrosine and 8-isoprostane activity increased
mainly in myocardial capillaries (Figure 1).
Because the small size of the LV biopsy samples, we
were able to determine NOS-III activity and cGMP content
in 9 hearts (before CPB and at the end of CPB), nitroty-
rosine-positive capillaries in 6 hearts, and 8-isoprostane-
positive capillaries in 5 hearts. NOS-III activity in cardiac
myocytes increased significantly from 34  10 gray units
(U) before CPB to 47  12 U at the end of CPB (P  .015,
Figure 2), and all hearts showed increased cGMP content in
both myocytes and endothelial cells. The number of nitro-
tyrosine-positive capillaries increased significantly from
36  29/mm2 before CPB to 82  47/mm2 at the end of
CPB (P .012, Figure 3), and the number of 8-isoprostane-
Figure 1. NOS-III activity and cGMP content were increased in both cardiac myocytes and endothelial cells at the
end of CPB (lower image line) compared with before CPB (upper image line). Nitrotyrosine and 8-isoprostane
activity increased mainly in coronary endothelial cells.
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positive capillaries increased significantly from 92  72/
mm2 before CPB to 209 108/mm2 at the end of CPB (P
.005, Figure 4). There was no correlation between the in-
creases in NOS-III, nitrotyrosine-positive capillaries, or
8-isoprostane-positive capillaries versus CPB duration or
aortic crossclamp time, respectively (r2  0.35). Global LV
ejection fraction, as assessed by means of FAC, was 53%
12% before CPB and 56%  12% after CPB (P  .47) but
was slightly decreased to 45%  14% at 4 hours after CPB
(P  .121).
Discussion
Our data show that cardioplegia-induced myocardial isch-
emia and reperfusion is associated with nitrotyrosine and
8-isoprostane formation mainly in the coronary endothe-
lium. Thus our study for the first time provides direct
evidence for ROS-mediated tyrosine nitration and lipid per-
oxidation of myocardial endothelial membranes in patients
subjected to cardioplegic arrest. Specifically, these data
suggest that peroxynitrite production caused by NOS-III
activation and increased NO release contributes to myocar-
dial injury after cardioplegic arrest and CPB.
Ischemia-reperfusion injury involves both cardiac myo-
cytes and coronary endothelial cells and appears to be a
major factor contributing to perioperative myocardial dam-
age.16 Although the pathophysiology of ischemia-reperfu-
sion injury is not yet fully understood, recent studies suggest
that ROS mediate the reperfusion injury that characterizes
metabolic, structural, and functional myocardial damage
associated with experimental coronary occlusion and reper-
fusion.1-3 Specifically, the role of NO and its ROS peroxyni-
trite (NO3) has been studied extensively; however, the
various studies have yielded conflicting data showing both
protective, as well as deleterious, NO effects during reper-
fusion. Cardioprotective NO effects include reduction of
neutrophil and platelet accumulation, inhibition of the re-
lease of cytotoxic mediators from neutrophils, direct cyto-
protective effects on both endothelial cells and cardiomyo-
cytes,16 and potential infarct size reduction.17 However,
increased NO release has been suggested to contribute to
reperfusion injury through peroxynitrite-mediated mem-
brane nitration, DNA synthesis inhibition,18 mitochondrial
Figure 2. At the end of CPB, NOS-III activity, as determined by
using television densitometry, was increased compared with that
before CPB. Bars represent mean values, with whiskers indicat-
ing corresponding SDs (n  9).
Figure 3. The number of nitrotyrosine-positive capillaries in hu-
man myocardium subjected to blood cardioplegia and reperfusion
was increased at the end of CPB compared with before CPB,
indicating injury induced by peroxynitrite, which was caused by
increased NO release. Bars represent mean values, with whis-
kers indicating corresponding SDs (n  6).
Figure 4. The number of 8-isoprostane-positive capillaries in
human myocardium subjected to blood cardioplegia and reper-
fusion was increased at the end of CPB compared with before
CPB, indicating oxygen-derived free radical–mediated lipid per-
oxidation. Bars represent mean values, with whiskers indicating
corresponding SDs (n  5).
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function inhibition,19 ribonucleotide reductase inhibition,20
and cytokine-induced myocardial contractile dysfunction.21
These data suggest that high NO levels during reperfusion
might be as deleterious as NO absence, and thus the role of
NO in ischemia and reperfusion might be dose dependent.
Our and other groups’ recent experimental work showed
that myocardial ischemia acts as the stimulus for NOS-III
activation, probably by inducing a conformational change
of the enzyme, resulting in increased NO release as indi-
cated by increased intracellular cGMP, NO’s intracellular
second messenger.22,23 Similarly, we have demonstrated, in
patients undergoing CABG, that cardioplegic arrest is asso-
ciated with NOS-III activation and increased cGMP in both
cardiac myocytes and endothelial cells, indicating increased
NO formation.12 To further elucidate the pathophysiology
of NO in ischemia and reperfusion, we intended to investi-
gate whether the increased NO release caused by NOS-III
activation results in myocardial tyrosine nitration as direct
evidence for tissue injury. In the present study the number
of nitrotyrosine-positive capillaries was significantly in-
creased after cardioplegia (Figure 3), indicating peroxyni-
trite formation in the myocardium. This is in agreement with
recent work by Hayashi and colleagues,13 who demon-
strated transcoronary peroxynitrite production during reper-
fusion in patients subjected to cardioplegic arrest. These
data suggest that peroxynitrite-mediated nitrotyrosine for-
mation caused by NOS-III activation and increased NO
release contributes to ROS-induced myocardial injury after
cardioplegic arrest and CPB.
In addition to peroxynitrite, other ROS, including hy-
droxyl radical (OH), superoxide radical (O2), and hydro-
gen peroxide (H2O2), have been suggested to be involved in
ischemia-reperfusion injury.1-3 One novel marker for ROS-
mediated membrane lipid oxidation is 8-isoprostane, the
stable end product of arachidonic acid oxidation.8,11 Inves-
tigators have determined 8-isoprostane as a marker of oxi-
dative stress in urine1 or blood24 of patients subjected to
percutaneous transluminal coronary angioplasty with acute
myocardial infarction; however, myocardial 8-isoprostane
formation and distribution caused by cardioplegia have not
been studied. In the present study the number of 8-isopros-
tane-positive capillaries in human myocardium was signif-
icantly increased at the end of CPB (Figure 4). These data
provide direct evidence for the contribution of ROS-medi-
ated membrane lipid oxidation to ischemia-reperfusion in-
jury in patients subjected to intermittent cold-blood cardio-
plegia. Interestingly, 8-isoprostane and nitrotyrosine
formation were mainly confined to coronary endothelium,
and only little staining was observed in cardiac myocytes
(Figure 1). This is probably because of the high cardiac
myocyte superoxide dismutase concentration,25 resulting in
only little myocyte ROS, and thus 8-isoprostane, as well as
nitrotyrosine, formation, even in the presence of increased
NO as NO, requires O2 to form NO3.16
Functional Implications
The functional correlate of ROS-mediated tissue injury is
myocardial stunning.2,3 Recent experimental studies have
shown that peroxynitrite production caused by increased
NO release is associated with irreversible cardiac function
impairment26 and higher mortality after coronary occlu-
sion27 and might be involved in cardiac apoptosis initia-
tion.10 Gupte and Okada28 recently demonstrated that ROS
mediate LV dysfunction through peroxynitrite production
that can be attenuated by NOS inhibition. In addition, 8-iso-
prostane has been shown to induce coronary vasoconstric-
tion associated with lactate production and contractile dys-
function.29 This coronary vasoconstriction persisted even
after removal of the ROS stimulus and might thus contribute
to the no-reflow phenomenon during reperfusion.30 In the
present study global LV ejection fraction, as measured by
means of FAC, was unchanged at 10 to 15 minutes after
separation from CPB but was slightly decreased at 4 hours
after CPB. Because these patients received continuous in-
fusion of 3.9  1.0 gmin1kg1 dopamine after CPB,
this mild LV dysfunction could reflect the functional isch-
emia-reperfusion injury associated with the structural LV
myocardial changes we observed. However, other factors,
including changed loading conditions or decreased endog-
enous catecholamines, could also have affected LV perfor-
mance.
Limitations of the Study
Because we did not include a treatment group (ie, addition
of a radical scavenger or NOS inhibitor) in our study, the
present findings have to be regarded as preliminary obser-
vations. Furthermore, ROS are only one aspect in the muti-
factorial process of ischemia-reperfusion injury, which in-
volves several factors, such as physical, metabolic, and
immunologic components. Thus the immunohistochemical
changes we observed might not be causally related to injury
directly caused by ischemia and reperfusion. Further studies
will have to show that pharmacologic interventions can
decrease the tissue content of ROS-induced changes and
that this will be associated with improved cardiac perfor-
mance to prove the clinical relevance of ROS. In addition,
the data of the present study do not allow us to separate
changes induced by CPB from those caused by cardioplegia
and reperfusion. Thus CPB itself could have been the source
of some or all ROS-mediated changes we observed. How-
ever, this is unlikely because we have previously shown that
LV NOS-III and cGMP were not activated when using
continuous antegrade coronary perfusion with normother-
mic CPB blood enriched with the -blocker esmolol, a
nonischemic myocardial protection method during aortic
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crossclamping.12 Together with the experimental data from
our and other groups,22,23 these data suggest that ischemia
acts as a stimulus for NOS-III activation. Future studies are
required to further elucidate the effect of CPB, cardioplegia,
and reperfusion on NOS activity regulation and ROS for-
mation, as well as their effects on tissues.
In conclusion, the data of the present study for the first
time provide direct evidence for ROS-induced myocardial
injury after ischemia and reperfusion in patients subjected to
cardioplegia and CPB. These findings suggest a rational
basis for investigation of ROS scavengers, selective NOS
inhibition, or both as adjuncts to reperfusion strategies.
Specifically, direct myocardial nitrotyrosine and 8-isopros-
tane detection in the experimental setting might be used to
provide a rational basis for dose selection before clinical
evaluation of antioxidant reperfusion strategies.
We thank Martin Hellmich, PhD, Department for Medical
Statistics, Informatics, and Epidemiology, University of Cologne
for statistical advice.
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